Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation

Cell Communication and Signaling

Volumn 7, Issue , 2009, Pages

  Resende, Rodrigo R ^a,b   Adhikari, Avishek ^c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Institute of Learning and Research Santa Casa of BH (IEPSC BH)   (Brazil)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955518226     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-7-20     Document Type: Review

References (274)

1. Evolutional study on acetylcholine expression. Y Horiuchi, R Kimura, N Kato, T Fujii, M Seki, T Endo, T Kato, K Kawashima, Life Sci 2003 72 1745 1756 12559395
2. Biological functions of keratinocyte cholinergic receptors. SA Grando, J Investig Dermatol Symp Proc 1997 2 41 48 9487015
3. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. I Wessler, CJ Kirkpatrick, K Racke, Clin Exp Pharmacol Physiol 1999 26 198 205 10081614
4. Extraneuronal cholinergic system in lymphocytes. K Kawashima, T Fujii, Pharmacol Ther 2000 86 29 48 10760545
5. Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. I Wessler, T Reinheimer, H Kilbinger, F Bittinger, CJ Kirkpatrick, J Saloga, J Knop, Life Sci 2003 72 2169 2172 12628475
6. The anti-apoptotic response of the Gq/11-coupled muscarinic receptor family. AB Tobin, DC Budd, Biochem Soc Trans 2003 31 1182 1185 14641022
7. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. K Kawashima, T Fujii, Front Biosci 2004 9 2063 2085 15353271
8. Role of acetylcholine receptors in proliferation and differentiation of P19 embryonal carcinoma cells. RR Resende, AS Alves, LR Britto, H Ulrich, Exp Cell Res 2008 314 1429 1443 18331729
9. Transcription of the M1 muscarinic receptor gene in neurons and neuronal progenitors of the embryonic rat forebrain. BP Williams, CJ Milligan, M Street, FM Hornby, J Deuchars, NJ Buckley, J Neurochem 2004 88 70 77 14675151
10. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. I Wessler, CJ Kirkpatrick, Br J Pharmacol 2008 154 1558 1571 18500366
11. Neuronal differentiation of P19 embryonal carcinoma cells modulates kinin B2 receptor gene expression and function. AH Martins, RR Resende, P Majumder, M Faria, DE Casarini, A Tarnok, W Colli, JB Pesquero, H Ulrich, J Biol Chem 2005 280 19576 19586 15767251
12. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation. RR Resende, P Majumder, KN Gomes, LR Britto, H Ulrich, Neuroscience 2007 146 1169 1181 17418494
13. Mechanism of acetylcholine-induced calcium signaling during neuronal differentiation of P19 embryonal carcinoma cells in vitro. RR Resende, KN Gomes, A Adhikari, LR Britto, H Ulrich, Cell Calcium 2008 43 107 121 17662384
14. From oocyte to neuron: do neurotransmitters function in the same way throughout development? GA Buznikov, YB Shmukler, JM Lauder, Cell Mol Neurobiol 1996 16 537 559 8956008
15. New evidence for neurotransmitter influences on brain development. P Levitt, JA Harvey, E Friedman, K Simansky, EH Murphy, Trends Neurosci 1997 20 269 274 9185309
16. Cellular acetylcholine content and neuronal differentiation. F Bignami, P Bevilacqua, S Biagioni, A De Jaco, F Casamenti, A Felsani, G Augusti-Tocco, J Neurochem 1997 69 1374 1381 9326265
17. Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. HM Schuller, Biochem Pharmacol 1989 38 3439 3442 2573356
18. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. R Maneckjee, JD Minna, Proc Natl Acad Sci USA 1990 87 3294 3298 2159143
19. Acetylcholine receptors and myasthenia. JM Lindstrom, Muscle Nerve 2000 23 453 477 10716755
20. Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors. J Changeux, SJ Edelstein, Curr Opin Neurobiol 2001 11 369 377 11399437
21. Nicotinic acetylcholine receptors: from structure to brain function. RC Hogg, M Raggenbass, D Bertrand, Rev Physiol Biochem Pharmacol 2003 147 1 46 12783266
22. Neuronal nicotinic receptors: from structure to pathology. C Gotti, F Clementi, Prog Neurobiol 2004 74 363 396 15649582
23. Presynaptic ionotropic receptors. DS McGehee, LW Role, Curr Opin Neurobiol 1996 6 342 349 8794090
24. Snake venom components and their applications in biomedicine. DC Koh, A Armugam, K Jeyaseelan, Cell Mol Life Sci 2006 63 3030 3041 17103111
25. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. GS Portugal, TJ Gould, Behav Brain Res 2008 193 1 16 18571741
26. Allosteric receptors after 30 years. JP Changeux, SJ Edelstein, Neuron 1998 21 959 980 9856454
27. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. P Seguela, J Wadiche, K Dineley-Miller, JA Dani, JW Patrick, J Neurosci 1993 13 596 604 7678857
28. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. RS Broide, FM Leslie, Mol Neurobiol 1999 20 1 16 10595869
29. M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. GL Forster, JS Yeomans, J Takeuchi, CD Blaha, J Neurosci 2002 22 C190 11756520
30. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. J Yeomans, G Forster, C Blaha, Life Sci 2001 68 2449 2456 11392612
31. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. AS Basile, I Fedorova, A Zapata, X Liu, T Shippenberg, A Duttaroy, M Yamada, J Wess, Proc Natl Acad Sci USA 2002 99 11452 11457 12154229
32. Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region. H Wang, K Ng, D Hayes, X Gao, G Forster, C Blaha, J Yeomans, Neuropsychopharmacology 2004 29 2126 2139 15213703
33. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies. ET Tzavara, FP Bymaster, RJ Davis, MR Wade, KW Perry, J Wess, DL McKinzie, C Felder, GG Nomikos, Faseb J 2004 18 1410 1412 15231726
34. Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats. B Di Cara, F Panayi, A Gobert, A Dekeyne, D Sicard, L De Groote, MJ Millan, Int J Neuropsychopharmacol 2007 10 383 399 16925890
35. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies. SS Hegde, M Mammen, JR Jasper, Curr Opin Investig Drugs 2004 5 40 49 14983972
36. The airway cholinergic system: physiology and pharmacology. K Racke, S Matthiesen, Pulm Pharmacol Ther 2004 17 181 198 15219263
37. Tiotropium bromide. SJ Keam, GM Keating, Treat Respir Med 2004 3 247 268 15350163
38. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. AV Terry Jr, JJ Buccafusco, J Pharmacol Exp Ther 2003 306 821 827 12805474
39. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. RT Bartus, Exp Neurol 2000 163 495 529 10833325
40. Sjogren's syndrome: evolving therapies. RI Fox, Expert Opin Investig Drugs 2003 12 247 254 12556218
41. Cholinergic dysfunction in vascular dementia. GC Roman, Curr Psychiatry Rep 2005 7 18 26 15717981
42. Therapeutic opportunities for muscarinic receptors in the central nervous system. CC Felder, FP Bymaster, J Ward, N DeLapp, J Med Chem 2000 43 4333 4353 11087557
43. Multiple allosteric sites on muscarinic receptors. NJ Birdsall, S Lazareno, A Popham, J Saldanha, Life Sci 2001 68 2517 2524 11392621
44. Therapeutic opportunities from muscarinic receptor research. RM Eglen, A Choppin, N Watson, Trends Pharmacol Sci 2001 22 409 414 11479003
45. Functional analysis of muscarinic acetylcholine receptors using knockout mice. M Matsui, S Yamada, T Oki, T Manabe, MM Taketo, FJ Ehlert, Life Sci 2004 75 2971 2981 15474550
46. Administration of nicotine to adolescent rats evokes regionally selective upregulation of CNS alpha 7 nicotinic acetylcholine receptors. TA Slotkin, MM Cousins, FJ Seidler, Brain Res 2004 1030 159 163 15567348
47. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. M Zoli, N Le Novere, JA Hill Jr, JP Changeux, J Neurosci 1995 15 1912 1939 7891142
48. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. I Aubert, D Cecyre, S Gauthier, R Quirion, J Comp Neurol 1996 369 31 55 8723701
49. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. JA Court, S Lloyd, M Johnson, M Griffiths, NJ Birdsall, MA Piggott, AE Oakley, PG Ince, EK Perry, RH Perry, Brain Res Dev Brain Res 1997 101 93 105 9263584
50. Expression of cholinergic system molecules during development of the chick nervous system. AS Torrao, FM Carmona, J Lindstrom, LR Britto, Brain Res Dev Brain Res 2000 124 81 92 11113515
51. Functional nicotinic acetylcholine receptor expression in stem and progenitor cells of the early embryonic mouse cerebral cortex. P Atluri, MW Fleck, Q Shen, SJ Mah, D Stadfelt, W Barnes, SK Goderie, S Temple, AS Schneider, Dev Biol 2001 240 143 156 11784052
52. Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients. M Oppitz, V Mobus, S Brock, U Drews, Gynecol Oncol 2002 85 159 164 11925137
53. Functional Nicotinic and Muscarinic Receptors on Mesenchymal Stem Cells. MJ Hoogduijn, A Cheng, PG Genever, Stem Cells Dev 2008 18393628
54. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. SJ Greco, C Zhou, JH Ye, P Rameshwar, Stem Cells Dev 2007 16 811 826 17999602
55. c-Src protein tyrosine kinase activity is required for muscarinic receptor-mediated DNA synthesis and neurogenesis via ERK1/2 and c-AMP-responsive element-binding protein signaling in neural precursor cells. WQ Zhao, DL Alkon, W Ma, J Neurosci Res 2003 72 334 342 12692900
56. Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins. N Bernardini, AI Levey, G Augusti-Tocco, J Peripher Nerv Syst 1999 4 222 232 10642090
57. Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma. CL Williams, VY Hayes, AM Hummel, JE Tarara, TJ Halsey, J Cell Biol 1993 121 643 654 8387530
58. Muscarinic cholinergic receptors in the human melanoma cell line SK-Mel 28: modulation of chemotaxis. A Boss, M Oppitz, U Drews, Clin Exp Dermatol 2005 30 557 564 16045692
59. Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis. LE Rimmaudo, E de la Torre, E Sacerdote de Lustig, ME Sales, Biochem Biophys Res Commun 2005 334 1359 1364 16040004
60. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. MB Newman, I Misiuta, AE Willing, T Zigova, RC Karl, CV Borlongan, PR Sanberg, Stem Cells Dev 2005 14 29 43 15725742
61. Activation of muscarinic M4 receptor augments NGF-induced pro-survival Akt signaling in PC12 cells. EH Wu, YH Wong, Cell Signal 2006 18 285 293 15979279
62. Malignant transformation of multipotent muscle-derived cells by concurrent differentiation signals. JB Pollett, KA Corsi, KR Weiss, GM Cooper, DA Barry, B Gharaibeh, J Huard, Stem Cells 2007 25 2302 2311 17569791
63. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. P Song, HS Sekhon, A Lu, J Arredondo, D Sauer, C Gravett, GP Mark, SA Grando, ER Spindel, Cancer Res 2007 67 3936 3944 17440109
64. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. M Janulis, S Silberman, A Ambegaokar, JS Gutkind, RM Schultz, J Biol Chem 1999 274 801 813 9873019
65. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue. M Blanco, MJ Robinson, Ann Diagn Pathol 2004 8 333 336 15614736
66. Different muscarinc receptors are involved in the proliferation of murine mammary adenocarcinoma cell lines. AJ Espanol, ME Sales, Int J Mol Med 2004 13 311 317 14719140
67. Identification and functional characterization of the muscarinic receptor M3 in the human keratinocyte cell line HaCaT. M Metzger, L Just, A Boss, U Drews, Cells Tissues Organs 2005 180 96 105 16113538
68. Human motor neuron differentiation from human embryonic stem cells. S Shin, S Dalton, SL Stice, Stem Cells Dev 2005 14 266 269 15969621
69. Functional Nicotinic and Muscarinic Receptors on Mesenchymal Stem Cells. MJCA Hoogduijn, PG Genever, Stem Cells and Development 2008
70. Modulation of ion channels by somatostatin and acetylcholine. M Inoue, M Yoshii, Prog Neurobiol 1992 38 203 230 1372125
71. Regulation of muscarinic acetylcholine receptor signaling. CJ van Koppen, B Kaiser, Pharmacol Ther 2003 98 197 220 12725869
72. Muscarinic signaling in carcinoma cells. CL Williams, Life Sci 2003 72 2173 2182 12628476
73. The pathway connecting m2 receptors to the nucleus involves small GTP-binding proteins acting on divergent MAP kinase cascades. JS Gutkind, P Crespo, N Xu, H Teramoto, OA Coso, Life Sci 1997 60 999 1006 9121367
74. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. B Nicke, K Detjen, CD Logsdon, J Biol Chem 1999 274 21701 21706 10419481
75. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest. D Burdon, R Patel, RA Challiss, JL Blank, Biochem J 2002 367 549 559 12126481
76. Pathways and roadblocks in muscarinic receptor-mediated growth regulation. JH Brown, V Sah, S Moskowitz, T Ramirez, L Collins, G Post, D Goldstein, Life Sci 1997 60 1077 1084 9121350
77. Elevated Rac1 activity changes the M3 muscarinic acetylcholine receptor-mediated inhibition of proliferation to induction of cell death. SH Shafer, CL Williams, Mol Pharmacol 2004 65 1080 1091 15102936
78. Activation of muscarinic receptors inhibits apoptosis in PC12M1 cells. L Lindenboim, R Pinkas-Kramarski, M Sokolovsky, R Stein, J Neurochem 1995 64 2491 2499 7760028
79. M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways. C Leloup, DM Michaelson, A Fisher, T Hartmann, K Beyreuther, R Stein, Cell Death Differ 2000 7 825 833 11042677
80. Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition. P De Sarno, SA Shestopal, TD King, A Zmijewska, L Song, RS Jope, J Biol Chem 2003 278 11086 11093 12538580
81. Exposure to nicotine during gestation interferes with the colonization of fetal bone marrow by hematopoietic stem/progenitor cells. N Serobyan, I Orlovskaya, V Kozlov, SK Khaldoyanidi, Stem Cells Dev 2005 14 81 91 15725747
82. Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway. DC Budd, EJ Spragg, K Ridd, AB Tobin, Biochem J 2004 381 43 49 15068397
83. The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties. DC Budd, J McDonald, N Emsley, K Cain, AB Tobin, J Biol Chem 2003 278 19565 19573 12649280
84. Effects of nicotine on proliferation and extracellular matrix production of human gingival fibroblasts in vitro. DA Tipton, MK Dabbous, J Periodontol 1995 66 1056 1064 8683418
85. Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. X Peng, V Gerzanich, R Anand, F Wang, J Lindstrom, Mol Pharmacol 1997 51 776 784 9145915
86. Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells. F Wang, ME Nelson, A Kuryatov, F Olale, J Cooper, K Keyser, J Lindstrom, J Biol Chem 1998 273 28721 28732 9786868
87. Effect of nicotine-treated epithelial cells on the proliferation and collagen production of gingival fibroblasts. C Giannopoulou, N Roehrich, A Mombelli, J Clin Periodontol 2001 28 769 775 11442737
88. Involvement of the muscarinic acetylcholine receptor in inhibition of cell migration. KA Varker, CL Williams, Biochem Pharmacol 2002 63 597 605 11992627
89. Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization through M3 and M4 muscarinic receptors. AI Chernyavsky, J Arredondo, J Wess, E Karlsson, SA Grando, J Cell Biol 2004 166 261 272 15263021
90. Intrathecal clonidine suppresses zymosan-induced peripheral leukocyte migration in a mouse air pouch model via activation of spinal muscarinic type 2 receptors and sympathoadrenal medullary activity. SY Yoon, HW Kim, DH Roh, YB Kwon, HJ Han, AJ Beitz, JH Lee, Neuropharmacology 2006 51 829 837 16814815
91. Ca2+-mobilization and cell contraction after muscarinic cholinergic stimulation of the chick embryo lens. M Oppitz, A Mack, U Drews, Invest Ophthalmol Vis Sci 2003 44 4813 4819 14578403
92. Contraction wave in the chick blastoderm induced by muscarinic stimulation. U Drews, W Mengis, Anat Embryol (Berl) 1990 182 447 454 2291489
93. Induction of cellular contractions in the human melanoma cell line SK-mel 28 after muscarinic cholinergic stimulation. M Sailer, M Oppitz, U Drews, Anat Embryol (Berl) 2000 201 27 37 10603091
94. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. JY Koh, E Palmer, CW Cotman, Proc Natl Acad Sci USA 1991 88 9431 9435 1658782
95. Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons. GM Yan, SZ Lin, RP Irwin, SM Paul, Mol Pharmacol 1995 47 248 257 7870032
96. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. BM Marte, J Downward, Trends Biochem Sci 1997 22 355 358 9301337
97. Regulation of neuronal survival by the serine-threonine protein kinase Akt. H Dudek, SR Datta, TF Franke, MJ Birnbaum, R Yao, GM Cooper, RA Segal, DR Kaplan, ME Greenberg, Science 1997 275 661 665 9005851
98. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. G Kulik, A Klippel, MJ Weber, Mol Cell Biol 1997 17 1595 1606 9032287
99. Activation of Akt/protein kinase B by G protein-coupled receptors. C Murga, L Laguinge, R Wetzker, A Cuadrado, JS Gutkind, J Biol Chem 1998 273 19080 19085 9668091
100. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J Desdouits-Magnen, F Desdouits, S Takeda, LJ Syu, AR Saltiel, JD Buxbaum, AJ Czernik, AC Nairn, P Greengard, J Neurochem 1998 70 524 530 9453546
101. Galphaq/11 signaling induces apoptosis through two pathways involving reduction of Akt phosphorylation and activation of RhoA in HeLa cells. H Ueda, R Morishita, S Narumiya, K Kato, T Asano, Exp Cell Res 2004 298 207 217 15242775
102. Chronic treatment with amyloid beta(1-42) inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling. J Novakova, L Mikasova, E Machova, V Lisa, V Dolezal, Brain Res 2005 1062 101 110 16256077
103. Functional muscarinic m3 receptor expressed in gastric cancer cells stimulates tyrosine phosphorylation and MAP kinase. M Kodaira, M Kajimura, K Takeuchi, S Lin, H Hanai, E Kaneko, J Gastroenterol 1999 34 163 171 10213113
104. Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells. JI Ukegawa, Y Takeuchi, S Kusayanagi, K Mitamura, J Cancer Res Clin Oncol 2003 129 272 278 12748850
105. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells. E Jimenez, M Montiel, J Cell Physiol 2005 204 678 686 15744749
106. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. P Song, HS Sekhon, Y Jia, JA Keller, JK Blusztajn, GP Mark, ER Spindel, Cancer Res 2003 63 214 221 12517800
107. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Z Xia, M Dickens, J Raingeaud, RJ Davis, ME Greenberg, Science 1995 270 1326 1331 7481820
108. A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. CN Anderson, AM Tolkovsky, J Neurosci 1999 19 664 673 9880587
109. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. R Yao, GM Cooper, Science 1995 267 2003 2006 7701324
110. Regulation of cell death protease caspase-9 by phosphorylation. MH Cardone, N Roy, HR Stennicke, GS Salvesen, TF Franke, E Stanbridge, S Frisch, JC Reed, Science 1998 282 1318 1321 9812896
111. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. C Page, HJ Lin, Y Jin, VP Castle, G Nunez, M Huang, J Lin, Anticancer Res 2000 20 407 416 10769688
112. Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. DC Henshall, T Araki, CK Schindler, JQ Lan, KL Tiekoter, W Taki, RP Simon, J Neurosci 2002 22 8458 8465 12351720
113. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. L del Peso, M Gonzalez-Garcia, C Page, R Herrera, G Nunez, Science 1997 278 687 689 9381178
114. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. SG Kennedy, AJ Wagner, SD Conzen, J Jordan, A Bellacosa, PN Tsichlis, N Hay, Genes Dev 1997 11 701 713 9087425
115. Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K/Akt pathways. QL Cui, E Fogle, G Almazan, Neurochem Int 2006 48 383 393 16439036
116. Cellular survival: a play in three Akts. SR Datta, A Brunet, ME Greenberg, Genes Dev 1999 13 2905 2927 10579998
117. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. V Janssens, J Goris, Biochem J 2001 353 417 439 11171037
118. AKT plays a central role in tumorigenesis. JR Testa, A Bellacosa, Proc Natl Acad Sci USA 2001 98 10983 10985 11572954
119. The activation of Akt/PKB signaling pathway and cell survival. G Song, G Ouyang, S Bao, J Cell Mol Med 2005 9 59 71 15784165
120. Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway. CY Yan, LA Greene, J Neurosci 1998 18 4042 4049 9592085
121. Neurotrophic factors prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase activation in PC12 cells. PJ Hartfield, AJ Bilney, AW Murray, J Neurochem 1998 71 161 169 9648862
122. Global expression of NGF promotes sympathetic axonal growth in CNS white matter but does not alter its parallel orientation. DB Pettigrew, YQ Li, Ct Kuntz, KA Crutcher, Exp Neurol 2007 203 95 109 16989811
123. Specific TrkA survival signals interfere with different apoptotic pathways. E Ulrich, A Duwel, A Kauffmann-Zeh, C Gilbert, D Lyon, B Rudkin, G Evan, D Martin-Zanca, Oncogene 1998 16 825 832 9484773
124. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. MP Scheid, V Duronio, Proc Natl Acad Sci USA 1998 95 7439 7444 9636168
125. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. RJ Crowder, RS Freeman, J Neurosci 1998 18 2933 2943 9526010
126. p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones. NT Bui, HG Konig, C Culmsee, E Bauerbach, M Poppe, J Krieglstein, JH Prehn, J Neurochem 2002 81 594 605 12065668
127. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. WH Zheng, S Kar, R Quirion, J Neurochem 2002 80 1049 1061 11953455
128. Nerve growth factor stimulation of p42/p44 mitogen-activated protein kinase in PC12 cells: role of G(i/o), G protein-coupled receptor kinase 2, beta-arrestin I, and endocytic processing. S Rakhit, S Pyne, NJ Pyne, Mol Pharmacol 2001 60 63 70 11408601
129. GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. X Lou, H Yano, F Lee, MV Chao, MG Farquhar, Mol Biol Cell 2001 12 615 627 11251075
130. Effect of pertussis toxin on insulin-induced signal transduction in rat adipocytes and soleus muscles. Y Kanoh, T Ishizuka, H Morita, M Ishizawa, A Miura, K Kajita, M Kimura, T Suzuki, H Sakuma, K Yasuda, Cell Signal 2000 12 223 232 10781929
131. Growth hormone and insulinlike growth factor 1 promote intestinal uptake and hepatic release of glutamine in sepsis. L Balteskard, K Unneberg, M Mjaaland, TG Jenssen, A Revhaug, Ann Surg 1998 228 131 139 9671077
132. Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform. S Kim, A Garcia, SP Jackson, SP Kunapuli, Blood 2007 110 4206 4213 17827385
133. Nerve growth factor signaling involves interaction between the Trk A receptor and lysophosphatidate receptor 1 systems: nuclear translocation of the lysophosphatidate receptor 1 and Trk A receptors in pheochromocytoma 12 cells. NA Moughal, C Waters, B Sambi, S Pyne, NJ Pyne, Cell Signal 2004 16 127 136 14607283
134. Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors. A Piiper, S Zeuzem, Curr Pharm Des 2004 10 3539 3545 15579051
135. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. K Natarajan, BC Berk, Methods Mol Biol 2006 332 51 77 16878685
136. Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin. Y Zhao, D He, R Stern, PV Usatyuk, EW Spannhake, R Salgia, V Natarajan, Cell Signal 2007 19 2329 2338 17689924
137. Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt. P Xie, DD Browning, N Hay, N Mackman, RD Ye, J Biol Chem 2000 275 24907 24914 10801799
138. Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes. A Clerk, IK Aggeli, K Stathopoulou, PH Sugden, Cell Signal 2006 18 225 235 15936927
139. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways. ZZ Chong, SH Lin, F Li, K Maiese, Curr Neurovasc Res 2005 2 271 285 16181120
140. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. ZZ Chong, F Li, K Maiese, Curr Neurovasc Res 2005 2 387 399 16375720
141. Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet beta-cells. SG Laychock, SM Sessanna, MH Lin, LD Mastrandrea, Endocrinology 2006 147 4705 4712 16794003
142. Role of sphingosine kinase in Ca(2+) signalling by epidermal growth factor receptor. D Meyer zu Heringdorf, H Lass, I Kuchar, R Alemany, Y Guo, M Schmidt, KH Jakobs, FEBS Lett 1999 461 217 222 10567700
143. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. J Xiang, DT Chao, SJ Korsmeyer, Proc Natl Acad Sci USA 1996 93 14559 14563 8962091
144. Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death. NS Wang, MT Unkila, EZ Reineks, CW Distelhorst, J Biol Chem 2001 276 44117 44128 11546793
145. Mammalian prion protein suppresses Bax-induced cell death in yeast. A Li, DA Harris, J Biol Chem 2005 280 17430 17434 15753097
146. H(2)O(2) induces upregulation of Fas and Fas ligand expression in NGF-differentiated PC12 cells: modulation by cAMP. F Facchinetti, S Furegato, S Terrazzino, A Leon, J Neurosci Res 2002 69 178 188 12111799
147. Palmitic and stearic fatty acids induce caspase-dependent and -independent cell death in nerve growth factor differentiated PC12 cells. JE Ulloth, CA Casiano, M De Leon, J Neurochem 2003 84 655 668 12562510
148. G-protein signaling abnormalities mediated by CD95 in salivary epithelial cells. XB Liu, R Masago, L Kong, BX Zhang, S Masago, N Vela-Roch, MS Katz, CK Yeh, GH Zhang, N Talal, H Dang, Cell Death Differ 2000 7 1119 1126 11139286
149. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. S Pugazhenthi, T Boras, D O'Connor, MK Meintzer, KA Heidenreich, JE Reusch, J Biol Chem 1999 274 2829 2837 9915817
150. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. WH Zheng, S Kar, R Quirion, J Biol Chem 2000 275 39152 39158 10995739
151. Rho family GTPases and neuronal growth cone remodelling: relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. R Kozma, S Sarner, S Ahmed, L Lim, Mol Cell Biol 1997 17 1201 1211 9032247
152. Stimulation of M3 muscarinic receptors induces phosphorylation of the Cdc42 effector activated Cdc42Hs-associated kinase-1 via a Fyn tyrosine kinase signaling pathway. DA Linseman, KA Heidenreich, SK Fisher, J Biol Chem 2001 276 5622 5628 11087735
153. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). K Kimura, M Ito, M Amano, K Chihara, Y Fukata, M Nakafuku, B Yamamori, J Feng, T Nakano, K Okawa, et al. Science 1996 273 245 248 8662509
154. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Y Wang, K Yoshioka, MA Azam, N Takuwa, S Sakurada, Y Kayaba, N Sugimoto, I Inoki, T Kimura, T Kuwaki, Y Takuwa, Biochem J 2006 394 581 592 16336212
155. The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation. C Fromm, OA Coso, S Montaner, N Xu, JS Gutkind, Proc Natl Acad Sci USA 1997 94 10098 10103 9294169
156. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. S Shaw, M Bencherif, MB Marrero, J Biol Chem 2002 277 44920 44924 12244045
157. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. A Brunet, A Bonni, MJ Zigmond, MZ Lin, P Juo, LS Hu, MJ Anderson, KC Arden, J Blenis, ME Greenberg, Cell 1999 96 857 868 10102273
158. Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. CM Cahill, G Tzivion, N Nasrin, S Ogg, J Dore, G Ruvkun, M Alexander-Bridges, J Biol Chem 2001 276 13402 13410 11124266
159. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. G Rena, AR Prescott, S Guo, P Cohen, TG Unterman, Biochem J 2001 354 605 612 11237865
160. Nicotine and apoptosis. R Zeidler, K Albermann, S Lang, Apoptosis 2007 12 1927 1943 17846896
161. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. H Mai, WS May, F Gao, Z Jin, X Deng, J Biol Chem 2003 278 1886 1891 12421819
162. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. KA West, J Brognard, AS Clark, IR Linnoila, X Yang, SM Swain, C Harris, S Belinsky, PA Dennis, J Clin Invest 2003 111 81 90 12511591
163. Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. Z Jin, F Gao, T Flagg, X Deng, J Biol Chem 2004 279 23837 23844 15037618
164. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. MP Scheid, KM Schubert, V Duronio, J Biol Chem 1999 274 31108 31113 10521512
165. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. SR Datta, H Dudek, X Tao, S Masters, H Fu, Y Gotoh, ME Greenberg, Cell 1997 91 231 241 9346240
166. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. XM Zhou, Y Liu, G Payne, RJ Lutz, T Chittenden, J Biol Chem 2000 275 25046 25051 10837473
167. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. X Fang, S Yu, A Eder, M Mao, RC Bast Jr, D Boyd, GB Mills, Oncogene 1999 18 6635 6640 10597268
168. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? HM Schuller, Nat Rev Cancer 2009 9 195 205 19194381
169. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. M Xin, X Deng, J Biol Chem 2005 280 10781 10789 15642728
170. Protein kinase Czeta abrogates the proapoptotic function of Bax through phosphorylation. M Xin, F Gao, WS May, T Flagg, X Deng, J Biol Chem 2007 282 21268 21277 17525161
171. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. P Dasgupta, R Kinkade, B Joshi, C Decook, E Haura, S Chellappan, Proc Natl Acad Sci USA 2006 103 6332 6337 16601104
172. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. T Kihara, S Shimohama, H Sawada, K Honda, T Nakamizo, H Shibasaki, T Kume, A Akaike, J Biol Chem 2001 276 13541 13546 11278378
173. Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells. F Berger, FH Gage, S Vijayaraghavan, J Neurosci 1998 18 6871 6881 9712657
174. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. ZZ Guan, WF Yu, A Nordberg, Neurochem Int 2003 43 243 249 12689604
175. Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. MV Hejmadi, F Dajas-Bailador, SM Barns, B Jones, S Wonnacott, Mol Cell Neurosci 2003 24 779 786 14664825
176. Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors. RR Jonnala, JH Graham 3rd, AV Terry Jr, JW Beach, JA Young, JJ Buccafusco, Synapse 2003 47 262 269 12539199
177. Arachidonic acid: toxic and trophic effects on cultured hippocampal neurons. S Okuda, H Saito, H Katsuki, Neuroscience 1994 63 691 699 7898670
178. Involvement of alpha 7 nicotinic acetylcholine receptors in gene expression of dopamine biosynthetic enzymes in rat brain. L Serova, EL Sabban, J Pharmacol Exp Ther 2002 303 896 903 12438507
179. Nicotine-induced FGF-2 mRNA in rat brain is preserved during aging. N Belluardo, G Mudo, M Blum, N Itoh, L Agnati, K Fuxe, Neurobiol Aging 2004 25 1333 1342 15465631
180. Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of alpha4 subunits of neuronal nicotinic receptors. YN Hsu, SC Edwards, L Wecker, J Neurochem 1997 69 2427 2431 9375675
181. Nicotine protects against arachidonic-acid-induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons. R Garrido, MP Mattson, B Hennig, M Toborek, J Neurochem 2001 76 1395 1403 11238724
182. Immunocytochemical localization of nicotinic acetylcholine receptor in rat cerebral cortex. H Nakayama, S Shioda, H Okuda, T Nakashima, Y Nakai, Brain Res Mol Brain Res 1995 32 321 328 7500844
183. Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. DK Berg, WG Conroy, J Neurobiol 2002 53 512 523 12436416
184. Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. S Trombino, A Cesario, S Margaritora, P Granone, G Motta, C Falugi, P Russo, Cancer Res 2004 64 135 145 14729617
185. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. HM Schuller, PK Tithof, M Williams, H Plummer 3rd, Cancer Res 1999 59 4510 4515 10493497
186. Functional role of nicotinic acetylcholine receptors in apoptosis in HL-60 cell line. D Gimonet, R Grailhe, P Coninx, F Antonicelli, B Haye, F Liautaud-Roger, Eur J Pharmacol 2003 482 25 29 14660001
187. Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. WL Heusch, R Maneckjee, Carcinogenesis 1998 19 551 556 9600337
188. CREB couples neurotrophin signals to survival messages. S Finkbeiner, Neuron 2000 25 11 14 10707967
189. Ras-related and MAPK signalling in neuronal plasticity and memory formation. C Mazzucchelli, R Brambilla, Cell Mol Life Sci 2000 57 604 611 11130460
190. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Y Zhu, C Culmsee, S Klumpp, J Krieglstein, Neuroscience 2004 123 897 906 14751283
191. Roles of nuclear factor kappaB in neuronal survival and plasticity. MP Mattson, C Culmsee, Z Yu, S Camandola, J Neurochem 2000 74 443 456 10646495
192. Transcriptional regulation by the phosphorylation-dependent factor CREB. B Mayr, M Montminy, Nat Rev Mol Cell Biol 2001 2 599 609 11483993
193. BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent. XM Zha, JF Bishop, MR Hansen, L Victoria, PJ Abbas, MM Mouradian, SH Green, Hear Res 2001 156 53 68 11377882
194. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. B Wasylyk, J Hagman, A Gutierrez-Hartmann, Trends Biochem Sci 1998 23 213 216 9644975
195. Functional characterization of the human basic fibroblast growth factor gene promoter. F Shibata, A Baird, RZ Florkiewicz, Growth Factors 1991 4 277 287 1764264
196. Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. RE Schweppe, AA Frazer-Abel, A Gutierrez-Hartmann, AP Bradford, J Biol Chem 1997 272 30852 30859 9388230
197. Muscarinic acetylcholine receptors involved in the regulation of neural stem cell proliferation and differentiation in vitro. C Zhou, ZX Wen, DM Shi, ZP Xie, Cell Biol Int 2004 28 63 67 14759770
198. Stem cell plasticity: a rare cell, not a rare event. YY Jang, SJ Sharkis, Stem Cell Rev 2005 1 45 51 17132874
199. Mammalian MAP kinase signalling cascades. L Chang, M Karin, Nature 2001 410 37 40 11242034
200. The contribution of nitric oxide and carbon monoxide to neuronal function and development. RR Resende, M Faria, H Ulrich, Central Nervous System Agents in Medicinal Chemistry 2007 7 85 96
201. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. CC Felder, Faseb J 1995 9 619 625 7768353
202. Adrenomedullin stimulates proline-rich tyrosine kinase 2 in vascular smooth muscle cells. H Iwasaki, M Shichiri, F Marumo, Y Hirata, Endocrinology 2001 142 564 572 11159826
203. Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. GJ Della Rocca, YV Mukhin, MN Garnovskaya, Y Daaka, GJ Clark, LM Luttrell, RJ Lefkowitz, JR Raymond, J Biol Chem 1999 274 4749 4753 9988712
204. Protein kinase C alpha activates RAF-1 by direct phosphorylation. W Kolch, G Heidecker, G Kochs, R Hummel, H Vahidi, H Mischak, G Finkenzeller, D Marme, UR Rapp, Nature 1993 364 249 252 8321321
205. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cdelta, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation. BH Shah, KJ Catt, Mol Pharmacol 2002 61 343 351 11809859
206. Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling. C Liebmann, FD Bohmer, Curr Med Chem 2000 7 911 943 10911023
207. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. G Pearson, F Robinson, T Beers Gibson, BE Xu, M Karandikar, K Berman, MH Cobb, Endocr Rev 2001 22 153 183 11294822
208. Control of the eukaryotic cell cycle by MAP kinase signaling pathways. MG Wilkinson, JB Millar, Faseb J 2000 14 2147 2157 11053235
209. Activation of phosphatidylinositol-3 kinase (PI-3K) and extracellular regulated kinases (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells. BS Li, W Ma, L Zhang, JL Barker, DA Stenger, HC Pant, J Neurosci 2001 21 1569 1579 11222647
210. G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. LF Allen, RJ Lefkowitz, MG Caron, S Cotecchia, Proc Natl Acad Sci USA 1991 88 11354 11358 1662393
211. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. JS Gutkind, EA Novotny, MR Brann, KC Robbins, Proc Natl Acad Sci USA 1991 88 4703 4707 1905013
212. Insights into the viral G protein-coupled receptor encoded by human herpesvirus type 8 (HHV-8). JP Couty, MC Gershengorn, Biol Cell 2004 96 349 354 15207903
213. HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks. HF Vischer, R Leurs, MJ Smit, Trends Pharmacol Sci 2006 27 56 63 16352349
214. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. BA Ballif, J Blenis, Cell Growth Differ 2001 12 397 408 11504705
215. Mirk/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival. SE Mercer, E Friedman, Cell Biochem Biophys 2006 45 303 315 16845176
216. Scaffold proteins of MAP-kinase modules. DN Dhanasekaran, K Kashef, CM Lee, H Xu, EP Reddy, Oncogene 2007 26 3185 3202 17496915
217. The role of p21ras in receptor tyrosine kinase signalling. GJ Pronk, JL Bos, Biochim Biophys Acta 1994 1198 131 147 7819271
218. Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. EJ van Corven, PL Hordijk, RH Medema, JL Bos, WH Moolenaar, Proc Natl Acad Sci USA 1993 90 1257 1261 7679495
219. Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras. WJ Koch, BE Hawes, LF Allen, RJ Lefkowitz, Proc Natl Acad Sci USA 1994 91 12706 12710 7809106
220. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. H Daub, FU Weiss, C Wallasch, A Ullrich, Nature 1996 379 557 560 8596637
221. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. S Eguchi, K Numaguchi, H Iwasaki, T Matsumoto, T Yamakawa, H Utsunomiya, ED Motley, H Kawakatsu, KM Owada, Y Hirata, et al. J Biol Chem 1998 273 8890 8896 9535870
222. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. BE Hawes, T van Biesen, WJ Koch, LM Luttrell, RJ Lefkowitz, J Biol Chem 1995 270 17148 17153 7615510
223. G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals. A Blaukat, A Barac, MJ Cross, S Offermanns, I Dikic, Mol Cell Biol 2000 20 6837 6848 10958680
224. Involvement of Ras and Raf in the Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase. S Winitz, M Russell, NX Qian, A Gardner, L Dwyer, GL Johnson, J Biol Chem 1993 268 19196 19199 8396128
225. Acetylcholine muscarinic m1 receptor regulation of cyclic AMP synthesis controls growth factor stimulation of Raf activity. M Russell, S Winitz, GL Johnson, Mol Cell Biol 1994 14 2343 2351 8139539
226. Activation of phosphatidylinositol 3 kinase by muscarinic receptors in astrocytoma cells. M Guizzetti, LG Costa, Neuroreport 2001 12 1639 1642 11409731
227. Coincident signalling between the Gi/Go-coupled delta-opioid receptor and the Gq-coupled m3 muscarinic receptor at the level of intracellular free calcium in SH-SY5Y cells. A Yeo, DS Samways, CE Fowler, F Gunn-Moore, G Henderson, J Neurochem 2001 76 1688 1700 11259487
228. Cell-specific extracellular signal-regulated kinase activation by multiple G protein-coupled receptor families in hippocampus. JL Berkeley, AI Levey, Mol Pharmacol 2003 63 128 135 12488545
229. Integration of G protein signals by extracellular signal-regulated protein kinases in SK-N-MC neuroepithelioma cells. AS Chan, WW Yeung, YH Wong, J Neurochem 2005 94 1457 1470 15992362
230. The m3 muscarinic acetylcholine receptor is coupled to mitogen-activated protein kinase via protein kinase C and epidermal growth factor receptor kinase. BE Slack, Biochem J 2000 348 Pt 2 381 387 10816433
231. ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. K Rosenblum, M Futter, M Jones, EC Hulme, TV Bliss, J Neurosci 2000 20 977 985 10648702
232. Activation of muscarinic acetylcholine receptors induces Ca(2+) mobilization in FRT cells. M Montiel, J Pavia, S Marsigliante, E Jimenez, Cell Signal 2001 13 207 212 11282459
233. Activation of second messenger-dependent protein kinases induces muscarinic acetylcholine receptor desensitization in rat thyroid epithelial cells. M Montiel, J Quesada, E Jimenez, Mol Cell Endocrinol 2004 223 35 41 15279909
234. The exchange factor Ras-GRF2 activates Ras-dependent and Rac-dependent mitogen-activated protein kinase pathways. WT Fan, CA Koch, CL de Hoog, NP Fam, MF Moran, Curr Biol 1998 8 935 938 9707409
235. RasGRP links T-cell receptor signaling to Ras. JO Ebinu, SL Stang, C Teixeira, DA Bottorff, J Hooton, PM Blumberg, M Barry, RC Bleakley, HL Ostergaard, JC Stone, Blood 2000 95 3199 3203 10807788
236. T cell activation in vivo targets diacylglycerol kinase alpha to the membrane: a novel mechanism for Ras attenuation. MA Sanjuan, B Pradet-Balade, DR Jones, AC Martinez, JC Stone, JA Garcia-Sanz, I Merida, J Immunol 2003 170 2877 2883 12626538
237. The M1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. SE Hamilton, NM Nathanson, J Biol Chem 2001 276 15850 15853 11278934
238. Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular ca(2+), PYK-2, and p60(src). SJ Keely, SO Calandrella, KE Barrett, J Biol Chem 2000 275 12619 12625 10777553
239. Differential regulation of FAK+ and PYK2/Cakbeta, two related tyrosine kinases, in rat hippocampal slices: effects of LPA, carbachol, depolarization and hyperosmolarity. P Derkinderen, J Siciliano, M Toutant, JA Girault, Eur J Neurosci 1998 10 1667 1675 9751139
240. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. X Li, JW Lee, LM Graves, HS Earp, Embo J 1998 17 2574 2583 9564040
241. Oxidative stress oppositely modulates protein tyrosine phosphorylation stimulated by muscarinic G protein-coupled and epidermal growth factor receptors. RS Jope, L Song, CA Grimes, L Zhang, J Neurosci Res 1999 55 329 340 10348664
242. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13- tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)py rrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. BH Shah, JA Olivares-Reyes, KJ Catt, Mol Pharmacol 2005 67 184 194 15465928
243. Signaling through transforming G protein-coupled receptors in NIH 3T3 cells involves c-Raf activation. P Crespo, N Xu, JL Daniotti, J Troppmair, UR Rapp, JS Gutkind, J Biol Chem 1994 269 21103 21109 8063729
244. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. BT Hawkins, RD Egleton, TP Davis, Am J Physiol Heart Circ Physiol 2005 289 212 219 15708958
245. Regulation of blood-brain barrier Na,K,2Cl-cotransporter through phosphorylation during in vitro stroke conditions and nicotine exposure. TJ Abbruscato, SP Lopez, K Roder, JR Paulson, J Pharmacol Exp Ther 2004 310 459 468 15051802
246. Expression of nicotinic acetylcholine receptors and subunit mRNA transcripts in cultures of neural crest cells. MJ Howard, MD Gershon, JF Margiotta, Dev Biol 1995 170 479 495 7649378
247. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. R De Simone, MA Ajmone-Cat, D Carnevale, L Minghetti, J Neuroinflammation 2005 2 4 15670336
248. Nicotinic receptor signaling in nonexcitable cells. G Sharma, S Vijayaraghavan, J Neurobiol 2002 53 524 534 12436417
249. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. BS Conklin, W Zhao, DS Zhong, C Chen, Am J Pathol 2002 160 413 418 11839560
250. Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. L Xu, X Deng, J Biol Chem 2006 281 4457 4466 16361262
251. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. VY Shin, WK Wu, KM Chu, HP Wong, EK Lam, EK Tai, MW Koo, CH Cho, Mol Cancer Res 2005 3 607 615 16317086
252. Long-term exposure to nicotine, via ras pathway, induces cyclin D1 to stimulate G1 cell cycle transition. M Chu, J Guo, CY Chen, J Biol Chem 2005 280 6369 6379 15574422
253. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. P Dasgupta, S Rastogi, S Pillai, D Ordonez-Ercan, M Morris, E Haura, S Chellappan, J Clin Invest 2006 116 2208 2217 16862215
254. Selective immunolesioning of the basal forebrain cholinergic system disrupts short-term memory in rats. G Leanza, J Muir, OG Nilsson, RG Wiley, SB Dunnett, A Bjorklund, Eur J Neurosci 1996 8 1535 1544 8758961
255. Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. DP Xie, LB Chen, CY Liu, CL Zhang, KJ Liu, PS Wang, Chin J Physiol 2004 47 89 94 15481791
256. The properties and regulation of functional acetylcholine receptors on chick ciliary ganglion neurons. JF Margiotta, DK Berg, VE Dionne, J Neurosci 1987 7 3612 3622 2445940
257. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor. HR Arias, J Neurosci Res 1996 44 97 105 8723217
258. Desensitization of neuronal nicotinic receptors of human neuroblastoma SH-SY5Y cells during short or long exposure to nicotine. E Sokolova, C Matteoni, A Nistri, Br J Pharmacol 2005 146 1087 1095 16230999
259. Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. C Mulle, P Benoit, C Pinset, M Roa, JP Changeux, Proc Natl Acad Sci USA 1988 85 5728 5732 2456580
260. Calcitonin gene-related peptide regulates phosphorylation of the nicotinic acetylcholine receptor in rat myotubes. K Miles, P Greengard, RL Huganir, Neuron 1989 2 1517 1524 2560647
261. Calcitonin gene-related peptide rapidly downregulates nicotinic receptor function and slowly raises intracellular Ca2+ in rat chromaffin cells in vitro. R Giniatullin, S Di Angelantonio, C Marchetti, E Sokolova, L Khiroug, A Nistri, J Neurosci 1999 19 2945 2953 10191312
262. A novel class of peptides with facilitating action on neuronal nicotinic receptors of rat chromaffin cells in vitro: functional and molecular dynamics studies. S Di Angelantonio, V Costa, P Carloni, L Messori, A Nistri, Mol Pharmacol 2002 61 43 54 11752205
263. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. S Leonard, J Gault, J Hopkins, J Logel, R Vianzon, M Short, C Drebing, R Berger, D Venn, P Sirota, et al. Arch Gen Psychiatry 2002 59 1085 1096 12470124
264. Role of L-type Ca2+ channels in neural stem/progenitor cell differentiation. M D'Ascenzo, R Piacentini, P Casalbore, M Budoni, R Pallini, GB Azzena, C Grassi, Eur J Neurosci 2006 23 935 944 16519658
265. Intracellular Ca(2+) Regulation During Neuronal Differentiation of Murine Embryonal Carcinoma and Mesenchymal Stem Cells. RR Resende, JL da Costa, AH Kihara, A Adhikari, E Lorencon, Stem Cells Dev 2008 19032055
266. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels. K Nagasawa, T Tarui, S Yoshida, F Sekiguchi, M Matsunami, A Ohi, K Fukami, S Ichida, H Nishikawa, A Kawabata, J Neurochem 2009 108 676 684 19054275
267. T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiation. K Hirooka, GE Bertolesi, ME Kelly, EM Denovan-Wright, X Sun, J Hamid, GW Zamponi, AE Juhasz, LW Haynes, S Barnes, J Neurophysiol 2002 88 196 205 12091545
268. The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. GE Bertolesi, C Shi, L Elbaum, C Jollimore, G Rozenberg, S Barnes, ME Kelly, Mol Pharmacol 2002 62 210 219 12130671
269. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. RP Mason, PR Leeds, RF Jacob, CJ Hough, KG Zhang, PE Mason, DM Chuang, J Neurochem 1999 72 1448 1456 10098848
270. Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. K Yamagata, S Ichinose, M Tagami, Hypertens Res 2004 27 271 282 15127885
271. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease. RD Brinton, JM Wang, Curr Alzheimer Res 2006 3 11 17 16472197
272. Panaxadiol glycosides that induce neuronal differentiation in neurosphere stem cells. JW Liu, SJ Tian, J de Barry, B Luu, J Nat Prod 2007 70 1329 1334 17663584
273. Antiproliferative effect of Ca2+ channel blockers on human epidermoid carcinoma A431 cells. J Yoshida, T Ishibashi, M Nishio, Eur J Pharmacol 2003 472 23 31 12860469
274. SLURP-1 and -2 in normal, immortalized and malignant oral keratinocytes. J Arredondo, AI Chernyavsky, SA Grando, Life Sci 2007 80 2243 2247 17280689